Delivery Order SPE2DB20D1100-SPE2DB23FD6X1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $14,505.92 for the supply of Otezla 30 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of February 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $30,671.51 for the supply of OTEZLA 30 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of January 24, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,900.52 delivery order is for the pharmaceutical product Otezla 30mg Tablet 60s. The contract is a firm fixed-price Delivery Order with an ultimate completion date of April 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $24,982.07, is for the delivery of Otezla 30 mg tablets. This is an open competition delivery order contract with a firm fixed price pricing type. The ultimate completion date for this contract is April 28, 2023. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, plays a critical role in supplying medical products to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Otezla 30 mg tablets. The contract, valued at $60,126.75, is a Firm Fixed Price Delivery Order with a completion date of May 3, 2023. The award is not set-aside and was made through full and open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,527.38 Firm Fixed Price Delivery Order covers the supply of Otezla 30 mg tablets for the DLA Troop Support Medical program. The contract has an ultimate completion date of April 26, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle...
- This federal contract award, valued at $5,192.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Otezla 30 mg tablets. The contract has a completion date of June 2, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order contract with a Firm Fixed Price pricing type. The contract, valued at $11,652.95, is for the delivery of the pharmaceutical product Otezla 30 mg Tablet 60s. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 10, 2023, with a completion date of January 11, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,230.20 Firm Fixed Price Delivery Order contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,600.43 with a completion date of November 17, 2023. It is a Firm Fixed Price contract for the purchase of Otezla 30 mg Tablets. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD6X1Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $36,946.98 for the pharmaceutical product Otezla 30 mg tablet 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 19, 2023. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000.00. These IDCs enable the efficient procurement of essential pharmaceutical products and medical supplies to support the healthcare needs of the military, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.9k | 9/18/23 |